Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Leukemia
|
October 24, 2020
Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine
S Pützer, L Varghese, J von Jan, et al.
Oncogene
|
June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
L Golmard, C Delnatte, A Laugé, et al.
Nature Communications
|
February 17, 2018
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
A Schrader, G Crispatzu, S Oberbeck, et al.
Leukemia
|
August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
E I Andersson, S Pützer, B Yadav, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Leukemia
|
October 24, 2020
Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine
S Pützer, L Varghese, J von Jan, et al.
Oncogene
|
June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
L Golmard, C Delnatte, A Laugé, et al.
Nature Communications
|
February 17, 2018
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
A Schrader, G Crispatzu, S Oberbeck, et al.
Leukemia
|
August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
E I Andersson, S Pützer, B Yadav, et al.
Page
of 7